Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-9,088
Closed -$970K 164
2021
Q2
$970K Sell
9,088
-3,624
-29% -$348K 0.04% 248
2021
Q1
$1.14M Sell
12,712
-3,108
-20% -$292K 0.04% 266
2020
Q4
$1.46M Sell
15,820
-131,560
-89% -$11.7M 0.04% 240
2020
Q3
$15.2M Buy
147,380
+109,380
+288% +$11.4M 0.37% 74
2020
Q2
$3.85M Hold
38,000
0.14% 158
2020
Q1
$2.56M Hold
38,000
0.11% 183
2019
Q4
$2.08M Hold
38,000
0.07% 293
2019
Q3
$1.42M Buy
+38,000
New +$1.48M 0.05% 355

Other funds holding DXCM

BP's DXCM Position: Q3 2021 in Review

BP sold out of DexCom (DXCM) in Q3 2021, closing a stake of 9,088 shares — an estimated $970K sold.

BP first reported a position in DXCM in Q3 2019 and held it in 8 quarters. The position peaked at $15.2M in Q3 2020. 797 funds tracked by Wall St. Rank hold DXCM as of Q3 2021.

  • BP reported no remaining DexCom position as of Q3 2021 after selling out during the quarter.
  • BP sold 9,088 DexCom shares in Q3 2021, an estimated $970K.
  • BP first reported a position in DexCom in Q3 2019 and held it in 8 quarters.
  • BP's DexCom position peaked at $15.2M in Q3 2020.
  • 797 funds tracked by Wall St. Rank held DexCom as of Q3 2021.

Based on BP's 13F filing for Q3 2021, filed 10 Nov 2021.